Reference is made to the stock exchange announcement on
The application period expired at 16:30 hours (CET) on
All offers to sell shares with limits at or below
Allocation notifications will be sent to shareholders having tendered shares in the Offering on or about
The settlement will be conducted on a normal delivery-versus-payment basis (DVP). Following settlement of the Offering, the Company will own 1,146,637 shares in the Company. The Company currently has 80,191,746 shares outstanding.
For further information, please contact:
nordhealth@carnegie.no or +47 22 00 93 40
charles.macbain@nordhealth.com
Mari Orttenvuori, CFO
mari.orttenvuori@nordhealth.com
About Nordhealth
Nordhealth is a publicly listed, fast-growing cloud-based healthcare SaaS company on a mission to redefine digital healthcare. We build software that empower veterinary and therapy professionals to provide the best possible care experiences to their patients. Our products serve more than 50,000 veterinary and therapy professionals across 13,000 clinics and hospitals located in over 30 countries.
Headquartered in
https://news.cision.com/nordhealth-oy/r/nordhealth-as--results-of-share-buy-back,c3889496
(c) 2023 Cision. All rights reserved., source